Type 2 Diabetes Trial, Recruiting NCT07196371 Sponsor: University of New Brunswick Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT07196371
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with type 2 diabetes and have a blood sugar control reading (called HbA1c) between 5.7% and 9.0%.
  • People who are not currently doing regular physical activity (less than 150 minutes of moderate to vigorous exercise per week).

Who may not be able to join:

  • People who have muscle, joint, or bone problems that would prevent them from doing exercise as part of the trial.
  • People whose medications have not been stable or consistent over the past 3 months.
  • People with conditions affecting blood flow in the limbs, such as peripheral vascular disease, which would make a specific type of training used in this trial unsafe (confirm with trial site).
  • People who have been told they have low iron levels or anaemia, or who are currently being treated for either of these conditions.
  • People who have been diagnosed with a condition that affects red blood cells, such as sickle cell anaemia (confirm with trial site for other qualifying conditions).
  • People who are currently living with a heart or cardiovascular condition that could make exercising safely difficult.
  • People who are currently taking a medication that could interfere with the accuracy of a heart rate monitor during exercise (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Martin Senechal, PhD, Cardiometabolic Exercise & Lifestyle Laboratory, Fredericton, New Brunswick

Phone: 506-451-6889

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of New Brunswick
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
1 December 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Rate of Recruitment; Rate of Enrollment; Adherence to the Intervention; Rate of Retention for Follow-Up Testing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov